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Our previous studies in the rat model of Parkinson’s disease (PD) cholinopathy
demonstrated the sleep-related alterations in electroencephalographic (EEG) oscillations
at the cortical and hippocampal levels, cortical drives, and sleep spindles (SSs) as
the earliest functional biomarkers preceding hypokinesia. Our aim in this study was to
follow the impact of a unilateral substantia nigra pars compacta (SNpc) lesion in rat
on the cortical and hippocampal sleep architectures and their EEG microstructures,
as well as the cortico-hippocampal synchronizations of EEG oscillations, and the
SS and high voltage sleep spindle (HVS) dynamics during NREM and REM sleep.
We performed unilateral SNpc lesions using two different concentrations/volumes of
6-hydroxydopamine (6-OHDA; 12 µg/1 µl or 12 µg/2 µl). Whereas the unilateral
dopaminergic neuronal loss>50% throughout the overall SNpc rostro-caudal dimension
prolonged the Wake state, with no change in the NREM or REM duration, there was a
long-lasting theta amplitude augmentation across all sleep states in the motor cortex
(MCx), but also in the CA1 hippocampus (Hipp) during both Wake and REM sleep.
We demonstrate that SS are the hallmarks of NREM sleep, but that they also occur
during REM sleep in the MCx and Hipp of the control rats. Whereas SS are always
longer in REM vs. NREM sleep in both structures, they are consistently slower in the
Hipp. The dopaminergic neuronal loss increased the density of SS in both structures
and shortened them in the MCx during NREM sleep, without changing the intrinsic
frequency. Conversely, HVS are the hallmarks of REM sleep in the control rats, slower
in the Hipp vs. MCx, and the dopaminergic neuronal loss increased their density in the
MCx, but shortened them more consistently in the Hipp during REM sleep. In addition,
there was an altered synchronization of the EEG oscillations between the MCx and Hipp
in different sleep states, particularly the theta and sigma coherences during REM sleep.
We provide novel evidence for the importance of the SNpc dopaminergic innervation in
sleep regulation, theta rhythm generation, and SS/HVS dynamics control. We suggest
the importance of the underlying REM sleep regulatory substrate to HVS generation
and duration and to the cortico-hippocampal synchronizations of EEG oscillations in
hemiparkinsonian rats.
Keywords: sleep, electroencephalography, sleep spindle, high voltage sleep spindle, substantia nigra pars
compacta, oscillations, motor cortex, hippocampus
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INTRODUCTION
Parkinson’s disease (PD) is a multisystem neurodegenerative
syndrome with a significant heterogeneity of motor and
non-motor features, whose prevalence increases with age
(Müller et al., 2013; Blesa and Przedborski, 2014). The main
symptoms of PD are manifested in the motor sphere and
include tremors, bradykinesia, muscle rigidity and slowness of
movements (Andrzejewski et al., 2016), whereas the non-motor
manifestations include cognitive changes, depression, memory
impairment, dementia, impaired olfaction and sleep disorders
(Afifi and Bergman, 2005; Rodriguez-Oroz et al., 2009).
The progressive neurodegeneration of the SNpc dopaminergic
neurons is considered to comprise the pathological substrate for
the classical motor symptoms of PD (Pienaar and van de Berg,
2013). Although in most reviews of PD, it is stated that the motor
signs first appear when about 50% of the substantia nigra (SN)
dopaminergic neurons are lost, there is a good consistency in the
available data which suggest that the motor signs appear when
there is about a 30% loss of the total SN neurons in comparison
to age-matched controls, or when about 80% of the striatal or
putaminal dopamine (DA) is lost (Cheng et al., 2010). Beside
the well-known reductions in dopaminergic pathways, there is
also evidence for alterations in the pedunculopontine tegmental
nucleus (PPT) cholinergic pathways in PD, which are associated
with impaired cognition, frequent falling, gait problems and
sleep disorders (Bohnen and Albin, 2011; Bohnen et al., 2012;
Müller et al., 2013; Petrovic et al., 2013a,b, 2014; Ciric et al.,
2016, 2017, 2018). Furthermore, there is evidence that PD is
preceded by REM sleep behavioral disorders (RBD) prior to
the dopaminergic neuropathology, and that these REM sleep
alterations are associated with the neuronal loss of the REM
sleep regulatory neuronal population, such as the sublaterodorsal
nucleus (Garcia-Lorenzo et al., 2013; Boucetta et al., 2016).
Animal models are the best tools to study the mechanisms
of PD pathogenesis, and the selection of each particular animal
model is very important and dependent on the specific goals
of the experimental study (Blesa and Przedborski, 2014). One
of the most used animal models of PD is the 6-OHDA
lesion of the nigrostriatal DA neurons in rats (Ge et al.,
2012; Blesa and Przedborski, 2014). For this rat model of PD,
6-OHDA, as a selective catecholaminergic neurotoxin, is injected
unilaterally into the SNpc, the medial forebrain bundle, the
striatum (Blandini et al., 2008; Blesa and Przedborski, 2014),
or intraventricularly (Rodriguez et al., 2001). All these toxin-
based animal models are suitable for studying sleep disturbances,
neuropsychiatric and cognitive deficits, alongside the non-motor
symptoms observed in PD that are increasingly recognized as
relevant to the prodromal disease-state (McDowell and Chesselet,
2012; Blesa and Przedborski, 2014).
The rhythmic oscillations of the neuronal populations
[hippocampal theta activity, occipital alpha waves, sleep spindles
(SSs)] may serve important physiological functions or may
underlie the basis of neurological diseases and rhythmic
movement disorders (Buzsaki et al., 1990). The American
Academy of Sleep Medicine defined SSs as a “train of distinct
waves which having a frequency of 11–16 Hz with a duration
≥0.5 s, usually maximal in amplitude over central brain regions”
(Iber et al., 2007). Moreover, abnormally synchronized oscillatory
activity in the cortical-basal ganglia loop is associated with motor
deficit in PD (Quiroga-Varela et al., 2013; Yang et al., 2015),
such as an abnormal beta synchronization (14–30 Hz) and high
voltage sleep spindle (HVS) (5–13 Hz) (Buzsaki and Silva, 2012;
Dejean et al., 2012). In addition there is evidence that the lack
of regulation of thalamo-cortical circuits is associated with an
altered SS and HVS dynamics during REM sleep (Ciric et al.,
2017, 2018). Since the SS and HVS result from the interactions
of the thalamic reticular, thalamo-cortical, hippocampal and
cortical neurons (Buzsaki et al., 1990; Steriade, 2006; Piantoni
et al., 2016), their characteristics may reflect the integrity of these
circuits or serve as the biomarkers of their failing regulation
in pathological condition (Warby et al., 2014). Therefore, more
attention has been paid to SS and HVS dynamics alterations,
notably in relation to various diseases such as schizophrenia,
epilepsy, autism, neurodegenerative diseases, and REM sleep
behavioral disorder (RBD) (Ge et al., 2012; Urakami et al., 2012;
Christensen et al., 2014; Sullivan et al., 2014; Yang et al., 2015).
Recent studies have shown that HVS were enhanced in the
neostriatum and substantia nigra pars reticulata (Dejean et al.,
2007), the globus pallidus (Ge et al., 2012) and subthalamic
nucleus (Magill et al., 2005) after dopamine depletion. It has also
been shown that SNpc dopamine depletion in 6-OHDA lesioned
rats increase the density and duration of HVS, as a special
pattern of spindle activity reflecting the state of the thalamo-
cortical regulatory network during PD (Yang et al., 2015). In
addition, there is also evidence for the role of dopaminergic
neurotransmission in regulating the sleep/wake cycle (Dahan
et al., 2007) as well as lesions of SNpc reducing the time spent
in REM sleep (Lima et al., 2007, 2008). Moreover, NREM sleep
disorder in the hippocampus alongside an altered HVS dynamic
during REM sleep in the hippocampus and motor cortex (MCx)
have recently been demonstrated as the earliest and long-lasting
biomarkers of RBD, expressed earlier than hypokinesia, in the
rat model of PD cholinopathy (Ciric et al., 2018). In addition,
the altered SS dynamic has been documented in coma, epilepsy,
stroke, and several forms of mental diseases (Sullivan et al., 2014),
while the HVS are associated with memory impairment and
the progression of brain dysfunction (Radek et al., 1994; Sales-
Carbonell et al., 2013). In the rat model of PD cholinopathy,
during REM sleep, the altered SS dynamic in the MCx and HVS
dynamic in the MCx and hippocampus reflected the thalamo-
cortical dysregulation (Ciric et al., 2017, 2018).
Therefore, on the basis of all the aforementioned studies,
particularly our previous studies in the rat model of PD
cholinopathy, which demonstrated the sleep-related alteration of
EEG oscillations, cortical drives, and SSs, as the earliest functional
biomarkers preceding hypokinesia, our aim in this study was to
follow the impact of a unilateral SNpc lesion in rats (specifically
hemiparkinsonian rats) on the cortical and hippocampal
sleep/wake state architectures, the EEG microstructures, the
SS/HVS dynamics and the cortico-hippocampal synchronization
of EEG oscillations along with the spontaneous locomotor
activity in different sleep states, in order to further investigate the
possible earliest functional biomarkers of PD.
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MATERIALS AND METHODS
Experimental Design
In this study the experiments were performed on 33 adult
male Wistar rats, which were 2-and-a-half month old at the
beginning of the study. We followed sleep, basal locomotor
activity and spatial memory abilities throughout the same aging
follow-up period (from 14 to 42 days following the surgical
procedure for the implantation of EEG and electromyographic,
EMG, electrodes for chronic sleep recording with or without the
unilateral SNpc lesion).
All behavioral assessments were performed after a week of the
sleep recording session, at each time point, and during the same
circadian phase (during inactive circadian phase for rats, from
9 a.m. to 3 p.m.).
We used 27 rats for sleep recording, divided into three groups:
the implanted controls (n = 10; Control-i), the unilaterally SNpc
lesioned rats, using 1 µl of 12 µg/µl of 6-hydroxy dopamine
hydrobromide salt (6-OHDA) solution (n = 8; 12 µg/1 µl SNpc
lesion), and the unilaterally SNpc lesioned rats, using 2 µl of
6 µg/µl of 6-OHDA solution (n= 9; 12 µg/2 µl SNpc lesion).
For the basal behavioral assessments, we included an
additional control group of untreated animals (n = 6; the
physiological control – Control-p).
Prior to surgery and throughout the experimental protocol,
the animals were maintained on a 12 h light-dark cycle (7 a.m.
lights on, 7 p.m. lights off), and were housed at 25◦C with free
access to food and water.
This study was carried out in accordance with the
recommendations of EEC Directive (2010/63/EU) on the
protection of animals used for experimental and other scientific
purposes, and the protocol was approved by Ethical Committee
for the Use of Laboratory Animals of the Institute for Biological
Research “Sinisa Stankovic” of the University of Belgrade
(Approval No. 2-21/10).
Surgical Procedure
The surgical procedures employed for the implantation of
EEG and EMG electrodes for chronic sleep recording have
been described previously (Ciric et al., 2015, 2018) and are
outlined below.
We implanted under ketamine/diazepam anesthesia (Zoletil
50, VIRBAC, France, 50 mg/kg; i.p.), in 2-and-a-half month
old rats, two epidural stainless-steel screw electrodes for EEG
cortical activity from the MCx (MCx; A/P: +1.0 mm from
bregma; R/L: 2.0 mm from sagittal suture; D/V: 1.0 mm from
the skull), and two stainless-steel teflon-coated wires (Medwire,
NY, United States) into the CA1 hippocampal regions (Hipp;
A/P: −3.6 mm from bregma; R/L: 2.5 mm from sagittal suture;
D/V: 2.5 mm from the brain surface, according to Paxinos and
Watson, 2005). “In addition, for assessment of skeletal muscle
activity (EMG) we implanted two stainless-steel teflon-coated
wires into the dorsal nuchal musculature and a stainless-steel
screw electrode in the nasal bone as a ground. All the electrode
leads were soldered to a miniature connector plug (39F1401,
Newark Electronics, Schaumburg, IL, United States), and the
assembly was fixed to the screw electrodes and skull using acrylic
dental cement (Biocryl-RN, Galenika a.d. Beograd, Serbia)”
(Ciric et al., 2015, 2018).
During the surgical procedure for the implantation of the
EEG and EMG electrodes, we performed the unilateral SNpc
lesions by using 1 µl of 12 µg/µl or 2 µl of 6 µg/µl 6-OHDA
(Sigma-Aldrich, St. Louis, MO, United States), dissolved in ice-
cold sterile saline (0.9% NaCl), and supplemented with 0.2%
ascorbic acid, which served as an anti-oxidant, into the right
SNpc (A/P: −5.3 mm from bregma; R: 2.4 mm from the sagittal
suture; D/V: 7.4 mm from the brain surface, according to Paxinos
et al., 2009). For the stereotaxically guided microinfusions, we
used a Digital Lab Standard Stereotaxic Instrument (Stoelting
Co., Europe) with Hamilton syringe (10 µl). The 6-OHDA
concentrations/volumes were chosen on the basis of previous
studies (Rodriguez et al., 1999; Gilmour et al., 2011; Pienaar and
van de Berg, 2013; Oliveira et al., 2017). The microinfusions were
introduced using a single pulse of 200 nl/min constant flow rate,
over 5 min for 1 µl, or over 10 min for 2 µl microinfusion.
To minimize the uptake of 6-OHDA by noradrenergic neurons,
30 min prior to the microinfusion, each rat received a bolus
of desipramine hydrochloride (28.42 mg/kg, i.p., Sigma-Aldrich,
Germany; pH= 7.4). Following the microinfusion, the Hamilton
syringe was left within the local brain tissue for 5 min before its
removal from the brain, allowing the 6-OHDA solution to diffuse
within the SNpc.
Recording Procedure
“At the end of surgical procedure, the scalp wounds were
sutured and the rats were allowed to recover for 13 days before
their adaptation to the recording cable and plexiglass chamber
(30 cm × 30 cm × 30 cm) for 1 day” (Petrovic et al., 2013a,b).
“The EEG and EMG activities were carried from the connector
plug on the rat head by cable, passed through a sealed port on
the recording box, and differentially recorded” (Ciric et al., 2015,
2016, 2018). “The differential mode consisted of six inputs (left
MCx, right MCx, left Hipp, right Hipp, left EMG, and right
EMG), each with a (+) on the left and a (−) on the right side,
and all with the same ground (a screw electrode implanted in the
nasal bone)”(Ciric et al., 2015, 2017, 2018).
“The EEG and EMG activities were displayed on a computer
monitor and stored on disk for further off-line analysis. After
conventional amplification and filtering (0.3–100 Hz band pass;
A-M System Inc. Model 3600, Carlsborg, WA, United States),
the analog data were digitized (at the sampling frequency of
256/s) and recorded for 6 h, during the normal inactive circadian
phase for rats (from 9 a.m. to 3 p.m.) using DataWave SciWorks
Experimenter Version 8.0 (DataWave Technologies, Longmont,
CO, United States)” (Ciric et al., 2015, 2017, 2018). In this study,
the sleep recording sessions of spontaneous sleep were done
in all rats 14 and 42 days after the surgical procedure and/or
the SNpc lesion.
Behavioral Assessments
Following the week of each sleep recording session, the basal
locomotor activity was tested, over three consecutive days, during
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the same circadian phase as for the previous sleep recording
sessions (from 9 a.m. to 3 p.m.).
The behavioral tests (basal locomotor activity, stereotypy-like
and vertical activities) were done after 30 min of habituation to
the experimental room, over 30 min (Ciric et al., 2018), by open-
field test using the Opto-Varimex Auto-Track System (Columbus
Instruments, Columbus, OH, United States). For the assessment
of basal locomotor activity, we used the distance traveled as a
measure. In addition to the basal locomotor activity, monitored
for 30 min (intra-session habituation), we also performed the
spatial habituation tests (SHT) over three consecutive days,
separated by 24 h intervals (inter-session habituation), and at
each time point in the follow-up period (14 and 42 days after
the surgical procedure of EEG and EMG implantation with or
without the unilateral SNpc lesion).
We note here that for all the behavioral assessments we
included an additional control group of non-implanted rats for
chronic sleep recording and non-lesioned rats (the physiological
controls – Control-p), and we used six rats for each experimental
group, except for that of the implanted controls (Control-i; the
rats only implanted for chronic sleep recording), were it was
seven rats.
For the statistical analyses of the basal locomotor activity,
we calculated the means of the distance traveled in 5 min periods
for the time-line profiles, and the means ± SE for totals for the
30 min periods.
Tissue Processing and Tyrosine
Hydroxylase (TH) Immunohistochemistry
for the SNpc Lesion Identification and
Quantification
The SNpc dopaminergic neuronal loss was identified by tyrosine
hydroxylase (TH) immunohistochemistry. “The rats were deeply
anesthetized and perfused transcardially, starting with a vascular
rinse until the liver had been cleared (200 ml of 0.9%
saline; perfusion speed of 40 ml/min); followed by a 4%
paraformaldehyde solution in 0.1 M PBS (200 ml; 100 ml at
40 ml/min, and then 30 ml/min), and finally with the 10% sucrose
solution in 0.1 M PBS (200 ml; 30 ml/min). The animals were
sacrificed and the brains were extracted, cleared of the meninges
and blood vessels, and immersed in 4% paraformaldehyde
overnight, and then in 30% sucrose solution for several days. The
brains were cut in a coronal plane into 40µm-thick sections using
a cryotome (Leica, Wetzlar, Germany), and the free- floating
sections were further stored in a cryoprotective buffer (0.05 M
phosphate buffer, 25% glycerol, and 25% ethylene glycol) at
−20◦C” (Ciric et al., 2017, 2018).
Immunohistochemistry was performed under the same
conditions for all the experimental samples, and the degree
of dopaminergic neuronal loss was quantified based on the
number of TH immunostained cells in the SNpc. “Brain
sections were initially thoroughly rinsed with 0.1 M PBS,
pH = 7.4. The endogenous peroxidase activity was neutralized
using 3% hydrogen peroxide/10% methanol in 0.1 M PBS for
15 min, and the non-specific binding was prevented by 60 min
incubation in 5% normal donkey serum (D9663, Sigma-Aldrich,
United States)/0.1 M PBS at RT” (Ciric et al., 2018). The sections
were further incubated for 48 h at 4◦C with a primary mouse
monoclonal anti-TH antibody (dil. 1:16000, T2928, Sigma-
Aldrich, United States) in a blocking solution with 0.5% Triton
X-100, and subsequently for 90 min in donkey anti-mouse IgG-
HRP (dil. 1:50, sc-2318, Santa Cruz, United States). Between
each immunolabeling step, the sections were washed in fresh
0.1 M PBS (3 × 5 min). Immunoreactive signals were visualized
using a diaminobenzidine solution [1% 3,3′-diaminobenzidine
(11208, Acros organics)/0.3% hydrogen peroxide/0.1 M PBS].
All the sections were finally mounted on slides, dehydrated in a
series of increasing ethanol solutions (Ethanol 70%, 96%, 100%,
Zorka Pharma, RS), placed in a clearing agent (Xylene, Zorka
Pharma, RS), mounted with DPX (Sigma-Aldrich, United States),
coverslipped and examined under a Zeiss Axiovert microscope
with a camera. To test immunolabeling specificity, the primary
antibodies were omitted in the control experiments.
All the tissue samples of the lesioned brains (three sections
for each rat) were grouped into three defined stereotaxic ranges
related to the overall SNpc rostro-caudal dimensions. We
quantified the dopaminergic neuronal loss by using Image J 1.46
software. Specifically, TH positively stained dopaminergic cells
were counted in three 40 µm thick coronal sections for each
brain, representing a certain stereotaxic range within the overall
rostro-caudal dimension of SNpc. There were three defined
stereotaxic ranges: 4.6–5.1; 5.2–5.7; and 5.8–6.3 caudally from
bregma. The number of TH positively stained cells was intended
to provide an estimate of the unilateral SNpc dopaminergic
neuronal loss (the lesioned SNpc/always the right SNpc) vs.
its corresponding contralateral control SNpc (always the left
SNpc), rather than to determine the absolute numbers of
dopaminergic neurons.
Thus, the dopaminergic neuronal loss was expressed for each
defined stereotaxic range, for each brain, and across the overall
SNpc rostro-caudal dimension, as the percentage difference of
TH positively stained cells with respect to its corresponding
contralateral control SNpc TH positively stained cells. To be
specific, all the percentage differences were expressed with respect
to the mean contralateral control absolute numbers for each
stereotaxic range of the SNpc, which was taken as 100%.
Data Analysis
The analysis of the sleep recorded signals was conducted using
software developed in MATLAB 6.5 (Petrovic et al., 2013a,b,
2014; Ciric et al., 2015, 2016; Lazic et al., 2015, 2017), and
upgraded to MATLAB R2011a.
Differentiation of the Sleep/Wake States
“We applied Fourier analysis to signals acquired throughout each
6-h recording (2160 10 s Fourier epochs), and each 10 s epoch was
differentiated as Wake, NREM or REM state for further analysis
of the Wake, NREM and REM related EEG amplitudes of all
the conventional frequency bands (δ = 0.3–4 Hz; θ = 4.1–8 Hz;
σ = 10.1–15 Hz; β = 15.1–30 Hz; γ = 30.1–50 Hz) of the control
and the SNpc lesioned rats” (Petrovic et al., 2013a,b, 2014).
“First, we extracted all the 10 s Wake epochs from each 6 h
recording, based on the product of sigma and theta frequency
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power on the y-axis, and the EMG power on the x-axis” (Petrovic
et al., 2013a,b, 2014). “Further, the differentiation of NREM and
REM 10 s epochs was done using the EMG power on the y- axis,
and the delta/theta power ratio on the x-axis” (Petrovic et al.,
2013a,b, 2014). “The differentiation of all Wake/NREM/REM
epochs was improved by using the logarithmic values of the
quantities on both EEG and EMG axes, and was finally achieved
using the two clusters K means algorithm” (Petrovic et al.,
2013a,b, 2014; Ciric et al., 2015, 2016; Lazic et al., 2015, 2017;
Saponjic et al., 2016).
In addition, we also analyzed the Wake/NREM/REM episode
dynamics, and the average “episode” duration of each state was
calculated by concatenated all bouts of each state and by dividing
the total duration obtained by the number of all bouts (10, 20,
and 30 s). All the values were expressed as means ± SE in
minutes. To be specific, we consider as an episode every single
10 s of Wake/NREM/REM (a 10 s “episode”) or a number of the
consecutive 10 s epochs of the same state of Wake/NREM/REM
(20 or 30 s “episodes,” and so on). Although the classical term
“episode” is not entirely appropriate to our form of data analysis
(Ciric et al., 2015, 2016; Lazic et al., 2017) we keep this term as it
is conventional.
Sleep State Related EEG Analysis
“To analyze the sleep/wake state related EEG amplitude changes
we calculated the group probability density distributions of
all the Wake, NREM and REM conventional EEG frequency
bands relative amplitudes over 6 h, of each experimental
group, using the Probability Density Estimate (PDE) routine
supplied with MATLAB R2011a. In order to eliminate any
influence from absolute signal amplitude variations on the
recordings, we computed the relative Fourier amplitudes”
(Petrovic et al., 2013a,b, 2014):
(RA)b =
∑
b Amp∑
tot Amp
, b = {δ, θ, σ, β, γ}.
“In this study, we particularly extracted the Wake/NREM/REM
10 s epochs by using the EEG of the MCx and Hipp for
sleep architecture analysis as well as for the state-related EEG
microstructures analysis from each brain structure by using the
PDE” (Petrovic et al., 2013a, 2014; Lazic et al., 2015, 2017; Ciric
et al., 2016, 2018; Saponjic et al., 2016).
“In addition, for each sleep/wake state and each frequency
band, PDE analysis was performed on the assembles of relative
amplitudes (Petrovic et al., 2013a,b; Lazic et al., 2015, 2017)
by pooling measured values from all animals belonging to
specific experimental group and at each time point of the
overall follow-up period (14 and 42 days after the surgical
procedure for implantation of EEG and EMG electrodes for
chronic sleep recording with or without SNpc lesion). For the
statistical analysis of the PDE/6 h of each EEG frequency-
specific relative amplitude (RA)b distribution, and in each state,
we calculated the relative amplitude means for Wake and REM
during each 30 min, while for NREM during each 60 min”
(Ciric et al., 2018).
Sleep State Related Cortico-
Hippocampal Coherences Analysis
Furthermore, we analyzed the Wake, NREM and REM cortico-
hippocampal coherences at each time point across the entire
follow-up period for each experimental group and for all the
conventional EEG frequency bands (Ciric et al., 2015, 2016),
using the EEGs of MCx and Hipp. The coherence values were
calculated using the “cohere” routine of the MATLAB R2011a
Signal Processing Toolbox. It actually computes the magnitude
squared coherence between the signals x(EEG of the MCx) and
y(EEG of the Hipp) as
Cxy(f ) =
∣∣Pxy(f )∣∣2
Pxx(f )Pyy(f )
where Pxy(f ) stands for the cross spectrum of x and y, while Pxx(f )
and Pyy(f ) denote the power spectra of the two signals.
All the Pxy, Pxx, and Pyy values were determined for every 10 s
of each 6 h recording, and for each frequency within the overall
0.3–50 Hz range, with a 0.1 Hz resolution (Ciric et al., 2015, 2016).
Specifically, the previously identified Wake/NREM/REM EEG
10 s epochs were concatenated and pooled for each time
point across the follow-up period, for each state, and for each
experimental group (Petrovic et al., 2014). Then, the coherence
values within each conventional EEG frequency band (δ, θ, σ,
β, and γ) were averaged for each spectrum, and finally, their
means were calculated, for each state, each time point across
the entire follow-up period, and for each experimental group.
For the statistical analysis, the mean coherence values were also
calculated for every 30 min of Wake and REM, and for every
60 min of NREM (Ciric et al., 2015, 2016).
Sleep Spindles Analysis
For the analysis of the SSs, we used from each rat 1 h of
NREM or REM sleep, extracted always between 3rd and 4th
hour of sleep recording. In order to identify the SS or HVS,
we combined automatic detection with the visual validation
of all the detected SS or HVS for their final visual extraction
and analysis. In particular, “the first step for automatic SS and
HVS detection during 1 h of NREM or REM sleep for each rat
and experimental group was to filter the EEG signals using the
11–17 Hz band pass filter for SS, or 4.1–10 Hz band pass filter
for HVS. Then, we applied the Continuous Wavelet Transform
with the mother wavelet “cmorl-2” MATLAB R2011a function,
providing a complex Morlet wavelet with determined central
frequency f0 = 2” (Adamczyk et al., 2015; Ciric et al., 2017, 2018).
In addition, all SS had a minimal duration of 0.5 s, while all HVS
had a minimal duration of 1 s.
But, “since we automatically detected many false positive or
negative SS or HVS, we had to visually correct all automatically
detected SS or HVS for their final extraction from each
NREM/REM sleep episode of each rat, and each experimental
group. Specifically, automatic detection helps us only to mark
SS or HVS, but not to extract them accurately in their overall
duration (from the onset to the end of oscillation). Therefore,
we had to visually correct the detections of SS and HVS,
to extract them more accurately for the analysis of their dynamics.
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We visually scrolled the automatically marked oscillations in the
EEG signal from each brain structure (the MCx or hippocampus),
and during each previously determined NREM/REM 10 s episode
based on the EEG and EMG.
Than we concatenated all visually detected and extracted SS
or HVS during NREM or REM of each group of rats for the
analysis of SS or HVS dynamic (mean density; mean intrinsic
frequency; mean duration per 1 h of NREM and REM sleep)”
(Lazic et al., 2018).
Statistical Analysis
All statistical analyses were performed using a Kruskal–Wallis
ANOVA (X2-values) with the Mann–Whitney U (z-values) two-
tailed post hoc test. The accepted level of significance was p≤ 0.05.
RESULTS
The Dopaminergic Neuronal Loss of
SNpc After Two Different 6-OHDA
Microinfusions
In this study we have demonstrated that by using two distinct
microinfusions, in terms of concentration/volume (12 µg/1 µl of
6-OHDA and 12µg/2µl of 6-OHDA), we induced dopaminergic
neuronal loss throughout the overall rostro-caudal dimension
of the SNpc consistently >60% by using the 12 µg/1 µl
microinjection (Figure 1A), while by using the 12 µg/2 µl
microinjection it was >56%, from 4.6 to 5.7 mm caudally
from bregma, with a maximum loss of >92% most caudally
(5.8–6.3 mm caudally from bregma; Figure 1B). The typical
individual examples of brain sections used for the quantification
of the dopaminergic neuronal loss in SNpc, representing each
stereotaxic range within its rostro-caudal dimension, from a rat
lesioned by a microinfusion of 12 µg/1 µl of 6-OHDA is depicted
in Figures 1C–E.
Since we always quantified the dopaminergic neuronal loss
of the lesioned SNpc (the right SNpc) vs. its corresponding
contralateral control SNpc (the left SNpc) of each stereotaxic
range, those were expressed as percentage differences with respect
to the mean contralateral control absolute numbers for each
stereotaxic range, taken as 100%; we have to note here that we
did not find a statistical difference (z ≥−1.89; p ≥ 0.07) between
the control absolute number of dopaminergic cells at any level of
the SNpc rostro-caudal dimension between the two experimental
groups (12 µg/1 µl of 6-OHDA and 12 µg/2 µl of 6-OHDA).
The Impact of SNpc Dopaminergic
Neuronal Loss on the Sleep Architecture
and Wake/NREM/REM Episode
Dynamics
Our results showed that the unilateral lesion of SNpc in both
experimental groups of rats (rats lesioned by 12 µg/1 µl of
6-OHDA or by 12 µg/2 µl of 6-OHDA), consistently increased
Wake duration, during their normal inactive circadian phase,
between 14 and 42 days following the SNpc lesion (X2 ≥ 6.02;
p ≤ 0.05; z ≥ −2.84; p ≤ 0.05; Table 1) in the MCx, and likewise
in the Hipp. On the other hand, the NREM and REM durations
were unaltered from 14 to 42 days following the SNpc lesion
(X2 ≥ 1.92; p ≥ 0.18; z ≥ −1.72; p ≥ 0.09; Table 1) in the MCx,
and the same was true in the Hipp.
Furthermore, the analysis of Wake/NREM/REM episode
dynamics showed that this sleep fragmentation was due to a
consistent increase in the mean number of Wake episodes from
14 to 42 days following the SNpc lesion in both the MCx and
the Hipp (X2 ≥ 5.93; p ≤ 0.05; z ≥ −2.74; p ≤ 0.05; Table 1).
In addition, there was a consistent prolongation of Wake episode
mean duration only in the MCx, and mainly following the SNpc
lesion using 12 µg/2 µl of 6-OHDA (X2 ≥ 5.65; p ≤ 0.05;
z ≥−2.31; p ≤ 0.04; Table 1).
However, the group distribution of the mean number of Wake
episodes over their durations (in minutes) showed that there
was a consistent increase in the number of Wake episodes of all
durations in the MCx as well as in the Hipp at each time point
during the follow-up period (Figure 2).
The Impact of SNpc Dopaminergic
Neuronal Loss on the Wake/NREM/REM
EEG Microstructures
In both experimental groups of rats (12 µg/1 µl SNpc lesion or
12 µg/2 µl SNpc lesion) the most consistent EEG microstructure
alteration from 14 to 42 days following the SNpc lesion,
and across all sleep states, was augmented theta amplitude
(Figures 3A,B) in the MCx (X2 ≥ 5.88; p ≤ 0.05; z ≥ −4.87;
p ≤ 0.04), and likewise in the Hipp (X2 ≥ 4.68; p ≤ 0.04;
z ≥ −5.12; p ≤ 0.04), but which was particularly long-lasting in
both structures during both Wake and REM sleep (Figure 3B).
In contrast to the MCx where an augmented theta amplitude,
at the onset of the SNpc lesion in both experimental groups of
rats, was transiently followed by an attenuated delta amplitude
across all sleep states (X2 ≥ 8.43; p ≤ 0.02; z ≥ −3.22; p ≤ 0.02;
data not shown), the delta amplitude was not changed in the Hipp
(X2 ≥ 0.73; p ≥ 0.11; data not shown).
On the other hand, in the Hipp an augmented theta amplitude
was consistently followed by an attenuated sigma amplitude, but
only during REM sleep, and only in rats that had been lesioned by
12 µg/2 µl of 6-OHDA (X2 ≥ 6.36; p≤ 0.04; z ≥−2.29; p≤ 0.04;
data not shown).
The Correlation of the SNpc
Dopaminergic Neuronal Loss With the
Wake Dynamic Changes and
Wake/NREM/REM Theta Amplitudes
When we correlated the means of the Wake duration/Wake
episode number of the MCx and Hipp with the dopaminergic
neuronal loss, for each defined stereotaxic range of the overall
SNpc rostro-caudal dimension, and for each rat of each
experimental group (12 µg/1 µl SNpc lesioned rats or 12 µg/2 µl
SNpc lesioned rats) we did not find any significant correlation, at
any time point over the follow-up period (r ≥ −0.50; p ≥ 0.07).
There was only a temporarily significant positive correlation in
the Wake prolongation in the Hipp with the SNpc dopaminergic
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FIGURE 1 | Tyrosine hydroxilase (TH) immunohistochemical identification and quantification of the unilateral substantia nigra pars compacta (SNpc) dopaminergic
neuronal loss. Quantified dopaminergic neuronal loss in the unilateral SNpc lesion caused by the microinfusion of 12 µg/1 µl 6-OHDA (A) and 12 µg/2 µl 6-OHDA
(B). Individual example of three sections used for the quantification of each SNpc lesioned brain (C–E), representing three defined stereotaxic ranges with an
identified SNpc partial lesion, caused by 12 µg/1 µl 6-OHDA, throughout the overall rostro-caudal SNpc dimension. The dopaminergic neuronal loss in this SNpc
was: 62.30% from 4.6 to 5.1 mm caudally from bregma; 74.47% from 5.2 to 5.7 mm caudally from bregma; and 93.34% from 5.8 to 6.3 mm caudally from bregma.
VTA, ventral tegmental area; ∗ – indicates the lesioned SNpc; Scale bar 200 µm. The scale bars of the upper (C–E) panels, representing only the typical brain
sections for the specific SNpc stereotaxic range, are not defined, since they were obtained by the acquisition of the images by using the 10× objective lens of the
Olympus BX-51 microscope, equipped with a motorized stage and CCD video camera (Pixelink, Ottawa, ON, Canada), and by using a superimage acquisition
option within the newCAST stereological software package (VIS-Visiopharm Integrator System, version 5.3.1.1640; Visiopharm; Denmark).
neuronal loss in the 12 µg/1 µl SNpc lesioned rats, 14 days after
the lesion (r = 0.51; p= 0.05; data not shown).
On the other hand, there was a sustained significant positive
correlation between the SNpc dopaminergic neuronal loss and
theta amplitude across the Wake/NREM/REM of the MCx only
in the 12 µg/1 µl SNpc lesioned rats (r ≥ 0.51; p ≤ 0.05;
Figures 4A,B), followed by a significant positive correlation in
the Hipp at the onset of the SNpc lesion (14 days after the
SNpc lesion), but only during Wake (r = 0.81; p = 10−4,
data not shown).
Conversely, this sustained functional coupling between the
SNpc dopaminergic neuronal loss and theta amplitude in the
MCx, and across Wake, NREM and REM, in the 12 µg/1 µl
SNpc lesioned rats (Figures 4A,B) was not present during any
sleep state or at any time point of the follow-up period, when
we correlated the theta amplitude of the MCx and Hipp with
the dopaminergic neuronal loss in the 12 µg/2 µl SNpc lesioned
rats (r ≥ −0.22; p ≥ 0.22). In this experimental group, we
demonstrated the higher percentage of dopaminergic neuronal
loss at the most caudal stereotaxic range of the SNpc rostro-
caudal dimension (Figure 1B).
It appears that the dopaminergic neuronal loss of >90% at
the most caudal stereotaxic range of the SNpc (about 30% higher
than in the 12 µg/1 µl SNpc lesioned rats) uncouples (abolishes)
the correlation of the dopaminergic neuronal loss with theta
amplitude in the 12 µg/2 µl SNpc lesioned rats, suggesting the
importance of the SNpc caudal dopaminergic neurons in theta
amplitude control.
The Impact of SNpc Dopaminergic
Neuronal Loss on SS and HVS Dynamics
During NREM and REM Sleep
We demonstrate that SS were present mostly during NREM sleep,
but that they also occurred during REM sleep in the control rats
(Table 2 and Figure 5A). Whereas SS were present in the MCx
in ≥80%, they were present in 50% of control rats in the Hipp
(Table 2). In the control rats, the SS during REM sleep were
longer than during NREM sleep in the MCx and Hipp (Table 2;
z ≥ −2.25, p ≤ 0.05). In addition, the SS during NREM sleep in
the Hipp were slower than the SS in the MCx of the control rats
(Table 2; z =−2.25, p= 0.02).
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TABLE 1 | The impact of SNpc dopaminergic neuronal loss on the Wake/NREM/REM durations and their episode dynamics at 14 and 42 days following the SNpc
lesions vs. controls in the motor cortex (MCx) and hippocampus (Hipp): the mean duration of Wake/NREM/REM sleep (minutes) with the mean numbers and mean
durations (minutes) of the Wake/NREM/REM episodes per 6 h of sleep ± SE.
Mean number of Mean duration of
Mean duration/6 h ± SE (min) episodes/6 h ± SE episodes/6 h ± SE (min)
Wake NREM REM Wake NREM REM Wake NREM REM
MCx 14 days
Control 55.24 ± 3.97 205.50 ± 12.88 98.93 ± 10.52 117.14 ± 9.68 310.57 ± 31.04 259.43 ± 33.09 0.48 ± 0.03 0.73 ± 0.12 0.40 ± 0.04
12 µg/1 µl SNpc lesion 77.69 ± 4.27 187.93 ± 10.58 94.05 ± 9.70 152.17 ± 10.12 320.67 ± 28.54 247.67 ± 32.97 0.52 ± 0.05 0.62 ± 0.08 0.38 ± 0.02
12 µg/2 µl SNpc lesion 89.45 ± 11.99 185.86 ± 7.70 84.36 ± 13.71 154.57 ± 12.35 261.14 ± 23.48 183.57 ± 30.50 0.67 ± 0.07 0.77 ± 0.08 0.39 ± 0.03
Hipp 14 days
Control 52.97 ± 4.83 236.20 ± 10.41 70.50 ± 8.41 97.20 ± 4.99 146.00 ± 2.14 78.40 ± 5.02 0.52 ± 0.02 1.71 ± 0.03 0.77 ± 0.08
12 µg/1 µl SNpc lesion 77.38 ± 2.80 213.33 ± 9.42 68.95 ± 8.57 153.00 ± 11.35 229.60 ± 21.75 199.60 ± 41.80 0.52 ± 0.03 0.95 ± 0.15 0.41 ± 0.05
12 µg/2 µl SNpc lesion 94.48 ± 4.87 212.00 ± 6.75 53.19 ± 7.44 176.67 ± 27.13 222.17 ± 27.15 88.83 ± 17.03 0.58 ± 0.06 1.05 ± 0.13 0.60 ± 0.09
MCx 42 days
Control 55.12 ± 5.96 189.21 ± 14.15 115.33 ± 18.03 134.00 ± 5.82 354.00 ± 59.40 296.50 ± 70.04 0.42 ± 0.05 0.64 ± 0.21 0.46 ± 0.11
12 µg/1 µl SNpc lesion 117.25 ± 19.08 154.08 ± 16.81 88.33 ± 14.72 231.75 ± 44.95 342.00 ± 29.68 257.25 ± 42.19 0.52 ± 0.04 0.47 ± 0.08 0.34 ± 0.01
12 µg/2 µl SNpc lesion 131.60 ± 16.39 150.47 ± 15.19 77.60 ± 13.64 211.20 ± 27.77 353.40 ± 23.77 271.20 ± 33.26 0.81 ± 0.14 0.48 ± 0.08 0.33 ± 0.02
Hipp 42 days
Control 60.33 ± 10.49 221.00 ± 12.55 78.33 ± 13.91 120.40 ± 11.03 217.40 ± 14.57 204.00 ± 36.33 0.40 ± 0.03 1.09 ± 0.13 0.43 ± 0.04
12 µg/1 µl SNpc lesion 89.42 ± 7.22 211.22 ± 11.47 59.03 ± 12.50 189.40 ± 22.78 256.80 ± 23.12 132.00 ± 27.58 0.50 ± 0.03 0.90 ± 0.14 0.38 ± 0.05
12 µg/2 µl SNpc lesion 114.72 ± 19.54 193.28 ± 14.21 51.67 ± 9.20 195.83 ± 24.06 242.83 ± 20.51 135.17 ± 27.05 0.57 ± 0.04 0.84 ± 0.12 0.40 ± 0.03
Bold numbers indicate the statistically significant mean values vs. their corresponding control values at p ≤ 0.05. All comparisons were made using the Mann–Whitney
U test.
FIGURE 2 | Wake episode dynamics in the MCx and hippocampus (Hipp) at 14 and at 42 days following the SNpc lesion caused by a microinfusion of 12 µg/1 µl
6-OHDA and 12 µg/2 µl 6-OHDA in contrast to the implanted controls (Control-i) - the group distributions of the mean number/6 h of Wake episodes over their
durations (minutes). In these log-log distributions each “horizontal stair” is placed above its corresponding duration, depicted on the x-axis in minutes – e.g., the
group mean number/6 h of 10 s episodes is placed above 10/60 = 0.17 min and so on. The first three episode durations are indicated below the “stair lines” of the
two upper panels as 10, 20, 30, presenting the group mean number/6 h of the Wake 10, 20, and 30 s episodes. The missing lines in the distributions depict the zero
group mean number of episodes that causes the logarithms to be identified as “not a number.”
The unilateral SNpc lesion increased the density of the SS
in the MCx, and likewise in the Hipp, only during NREM
sleep (Table 2; z ≥ −3.61, p ≤ 0.005), but it decreased their
duration (z ≥ −2.27, p ≤ 0.05), with no change in their intrinsic
frequency (z ≥ −1.38, p ≥ 0.69), only in the MCx (Table 2
and Figures 5B–D).
In this study, we demonstrate that HVS occurred mainly
during the REM sleep of control rats (Table 3 and Figure 5E).
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FIGURE 3 | Unilateral dopaminergic neuronal loss in the SNpc augmented theta amplitude across Wake, NREM and REM sleep in the MCx and hippocampus (Hipp)
14 (A) and 42 (B) days following the SNpc lesion caused by a microinfusion of 12 µg/1 µl 6-OHDA (12 µg/1 µl SNpc lesion) and 12 µg/2 µl 6-OHDA (12 µg/2 µl
SNpc lesion). Theta amplitude augmentation following the unilateral SNpc lesion was particularly long-lasting in the MCx and Hipp during both Wake and REM sleep.
As with the SS during NREM sleep in the Hipp (Figure 5A), HVS
are slower in the Hipp than in the MCx during the REM sleep of
the control rats (Table 3 and Figure 5E; z =−2.43, p= 0.02).
Moreover, the unilateral SNpc lesion mainly and consistently
increased HVS density in the MCx (Table 3 and Figure 5F;
z≥−2.29, p≤ 0.03) during REM sleep, alongside their decreased
duration, but more consistently in the Hipp (z ≥ −4.50,
p ≤ 0.002), with no change in their intrinsic frequency (Table 3;
z ≥−1.32, p ≥ 0.19).
The Impact of SNpc Dopaminergic
Neuronal Loss on the EEG Oscillations
Synchronization Across All Sleep States
We demonstrate that 14 days following the SNpc lesion (Figure 6
Day 14) the theta, sigma and beta synchronizations between the
MCx and Hipp increased across all sleep states in the rats lesioned
by 12 µg/2 µl of 6-OHDA (X2 ≥ 5.87; p ≤ 0.05; z ≥ −2.62;
p ≤ 0.05). Moreover, while delta synchronization decreased, the
gamma synchronization increased during Wake (X2 ≥ 6.42;
p ≤ 0.04; z ≥−3.76; p ≤ 0.03).
On the other hand, the sigma and beta synchronizations
decreased during Wake and NREM in the rats lesioned
with 12 µg/1 µl of 6-OHDA (X2 ≥ 15.65; p ≤ 10−4;
z ≥ −2.61; p ≤ 0.04). In addition, there was a decreased theta
synchronization during NREM (X2= 17.05; p= 10−4; z=−2.78;
p = 0.01), and decreased delta and gamma synchronizations
during REM sleep (X2 ≥ 5.08; p ≤ 0.05; z ≥−2.31; p ≤ 0.05).
During Wake, 42 days after the SNpc lesion using 12 µg/2 µl
of 6-OHDA (Figure 6 Day 42, upper panel), the increased
synchronizations of theta, sigma, beta and gamma (X2 ≥ 16.61;
p = 10−4; z ≥ −3.61; p ≤ 0.04), alongside the decreased delta
synchronization (X2 = 20.45; p = 10−4; z = −2.51; p = 0.01)
were sustained. Conversely, during Wake, after the SNpc lesion
using 12 µg/1 µl of 6-OHDA (Figure 6 Day 42, upper panel),
the decreased sigma and beta synchronizations were sustained
(X2 ≥ 16.61; p = 10−4; z ≥ −3.32; p ≤ 0.003), alongside
the decreased delta and theta synchronizations (X2 ≥ 20.45;
p= 10−4; z ≥−3.64; p ≤ 0.002).
However, the most striking result was that the divergences of
the theta and sigma coherences (desynchronizations) between
the MCx and the Hipp, in the rats lesioned using 12 µg/1 µl
Frontiers in Neuroscience | www.frontiersin.org 9 February 2019 | Volume 13 | Article 148
fnins-13-00148 February 25, 2019 Time: 12:10 # 10
Ciric et al. Sleep and Sleep Oscillations in the Hemiparkinsonian Rat
FIGURE 4 | Functional coupling between the dopaminergic neuronal loss of the substantia nigra pars compacta (SNpc) and theta amplitude during Wake, NREM
and REM in the MCx. The significant positive linear correlations (r ≥ 0.51; p ≤ 0.05) between the Wake/NREM/REM relative theta amplitudes in the MCx and the
dopaminergic (DA) neuronal loss throughout the overall SNpc rostro-caudal dimension at 14 (A) and 42 (B) days following the SNpc lesion caused by 12 µg/1 µl
6-OHDA (12 µg/1 µl SNpc lesion).
vs. 12 µg/2 µl of 6-OHDA, became convergent (synchronized)
42 days after the SNpc lesion, but only during REM sleep
(Figure 6 Day 42, bottom panel).
To be specific, even in the cases without change vs. the controls
during Wake and REM sleep in the rats lesioned using 12µg/1µl
of 6-OHDA, the increased theta and sigma synchronizations
between MCx and Hipp (X2 ≥ 8.87; p≤ 0.01; z≥−2.56; p≤ 0.02)
became a common feature only during REM sleep, in both
lesioned group of rats (Figure 6 Day 42, bottom panel). Besides
this phenomenon during REM sleep, there were also increased
beta and gamma synchronizations during REM (X2 ≥ 9.75;
p ≤ 0.01; z ≥ −2.66; p ≤ 0.01), as well as during NREM
(X2 ≥ 8.09; p ≤ 0.02; z ≥ −3.28; p ≤ 0.01), but only in those
rats lesioned using 12 µg/2 µl of 6-OHDA.
The Impact of SNpc Dopaminergic
Neuronal Loss on Spontaneous
Locomotor Activity
Our results show that the unilateral SNpc lesion did not alter
spontaneous basal locomotor activity during the overall follow-
up period (from 14 to 42 days after lesion) in either experimental
group of SNpc lesioned rats (X2 ≥ 1.34; p ≥ 0.47).
Figure 7A depicts the means of basal locomotor activity
during all the examined time points calculated per 5 min (left
panels) and per 30 min intervals (right panels) in all rats.
In addition, we did not show any augmentation of stereotypic
activity or an alteration in the vertical activity during the overall
follow-up period after the SNpc lesion in either group of SNpc
lesioned rats (X2 ≥ 1.23; p ≥ 0.24; data not shown).
Although in this study we did not examine memory
abilities specifically, we demonstrated the long-lasted alteration
of habituatal responses in both groups of SNpc lesioned rats
vs. Control-p and vs. Control-i, that indicate impaired spatial
memory abilities in the SNpc lesioned rats. Figure 7B depicts the
inter-session habitual responses in the Control-p, the Control-i,
and in both groups of SNpc lesioned rats. The disordered inter-
session habitual responses were present on both Days 14 and 42
in both groups of SNpc lesioned rats (Figure 7B, bottom panels).
DISCUSSION
Our results show that the unilateral dopaminergic neuronal
loss of >50% throughout the overall SNpc rostro-caudal
dimension (Figure 1) increased Wake duration, with no
change in NREM and REM duration, due to the increased
number and duration of Wake episodes in the MCx, as well
as in the hippocampus (Table 1 and Figure 2). In addition,
there was an augmented theta amplitude across different
sleep states in the MCx and in the hippocampus (Figure 3).
Moreover, this theta amplitude augmentation, caused by
impaired SNpc dopaminergic innervation, lasted throughout
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TABLE 2 | Sleep spindles (SS) dynamics during NREM and REM sleep.
SS
MCx n nSS Density/h (1/min) NREM/REM dur/h (min) SSdur/h (min) SSdur (s) SSf (Hz)
NREM
Control 8/10 (80%) 83 0.24 ± 0.03 25.63 ± 2.12 1.80 1.34 ± 0.06 13.25 ± 0.09
12 µg/1 µl SNpc lesion 8/8 (100%) 269 0.86 ± 0.12 26.55 ± 1.89 5.50 1.23 ± 0.03 13.27 ± 0.05
12 µg/2 µl SNpc lesion 9/9 (100%) 275 0.70 ± 0.09 23.23 ± 5.58 5.58 1.20 ± 0.03 13.23 ± 0.05
REM
Control 9/10 (90%) 36 0.24 ± 0.03 7.25 ± 0.62 0.96 1.59 ± 0.13∗∗ 13.44 ± 0.16
12 µg/1 µl SNpc lesion 7/8 (88%) 38 0.36 ± 0.06∗∗ 8.69 ± 0.76 0.96 1.52 ± 0.08∗∗ 13.16 ± 0.14
12 µg/2 µl SNpc lesion 8/9 (89%) 29 0.14 ± 0.02∗∗ 8.16 ± 0.85 0.65 1.35 ± 0.09∗∗ 12.76 ± 0.19∗∗
Hipp
NREM
Control 5/10 (50%) 19 0.05 ± 0.00∗ 25.63 ± 2.12 0.41 1.28 ± 0.12 12.74 ± 0.25∗
12 µg/1 µl SNpc lesion 8/8 (100%) 121 0.30 ± 0.04∗ 26.55 ± 1.89 2.40 1.19 ± 0.05 12.65 ± 0.07∗
12 µg/2 µl SNpc lesion 9/9 (100%) 106 0.29 ± 0.04∗ 23.23 ± 5.58 2.08 1.18 ± 0.05 12.71 ± 0.08∗
REM
Control 5/10 (50%) 10 0.19 ± 0.03∗∗ 7.25 ± 0.62 0.30 1.79 ± 0.21∗∗ 12.90 ± 0.31
12 µg/1 µl SNpc lesion 5/8 (63%) 6 0.11 ± 0.02∗/∗∗ 8.69 ± 0.76 0.16 1.56 ± 0.22 12.73 ± 0.28
12 µg/2 µl SNpc lesion 4/9 (44%) 8 8.16 ± 0.85
n, number of rats; nSS, total number of extracted SS used for analysis of SS dynamic; density/h, mean frequency of SS per hour of NREM/REM sleep (1/min); NREM/REM
dur/h, mean NREM/REM duration (minutes); SSdur/h, total duration of SS extracted during 1 h of NREM/REM sleep (minutes); SS dur, mean SS duration (seconds); SSf,
mean SS intrinsic frequency (Hz).
Bold numbers indicate the statistically significant mean values vs. their corresponding control values at p ≤ 0.05; ∗ indicates statistically significant inter-structure mean
values at p ≤ 0.05; ∗∗ indicates statistically significant NREM/REM mean values at p ≤ 0.05. All comparisons were made using the Mann–Whitney U test.
There were no mean values in the gray rows, and they were not compared, since the SS were present in less than 50% of the rats.
the overall follow-up period across Wake/NREM/REM
in the MCx (Figures 3A,B), but only during Wake and
REM sleep in the hippocampus (Figure 3B, bottom
panels). In addition, beside the long-lasting theta amplitude
augmentation, there was a sustained positive functional
coupling between the theta amplitude augmentation in
the MCx and the SNpc dopaminergic neuronal loss across
Wake/NREM/REM, but only in the 12 µg/1 µl SNpc lesioned
rats (Figures 4A,B).
We have to mention here, that since we recorded sleep
for 6 h during the normal inactive circadian phase for rats
(from 9 a.m. to 3 p. m.), an increased Wake duration in the
hemiparkinsonian rats represents severe sleep fragmentation,
not prolonged wakefulness. In addition, we have shown by the
analysis of the Wake/NREM/REM episode dynamics that this
sleep fragmentation was due to a consistent increase in the mean
number of Wake episodes from 14 to 42 days following the SNpc
lesion in both the MCx and the Hipp (Table 1). In addition,
there was the consistent prolongation of the mean duration of
Wake episodes only in the MCx, mainly following the SNpc
lesion using 12 µg/2 µl of 6-OHDA (Table 1). However, the
group distribution of the mean number of Wake episodes over
their durations enable us to show that there was a consistent
increase in the Wake episodes number of all durations in the
MCx, as well as in the Hipp, for each time point of the follow-up
period (Figure 2).
In addition, in order to lesion the SNpc selectively, within
the limits of the SNpc, we used two different microinfusions of
6-OHDA in terms of volume (1 µl vs. 2 µl) and concentration
(12 µg/µl vs. 6 µg/µl). We induced a significantly higher
percentage of dopaminergic neuronal loss only at the most
caudal stereotaxic range of the SNpc (92.64%) by using the
microinfusion of 12 µg/2 µl 6-OHDA vs. the microinfusion
of 12 µg/1 µl 6-OHDA (Figures 1A,B). However, this local,
topographically higher dopaminergic neuronal loss did not
induce any different effect in the sleep architecture, the
sleep/wake state related EEG microstructures, or on the SS or
HVS dynamics.
On the other hand, by contrast to the 12 µg/1 µl SNpc
lesioned rats, a dopaminergic neuronal loss >90% at the most
caudal stereotaxic range of the SNpc rostro-caudal dimension
uncoupled (abolished) the correlation of dopaminergic neuronal
loss with theta amplitude in the 12 µg/2 µl SNpc lesioned rats,
suggesting the importance of the caudal dopaminergic neurons
of SNpc in theta amplitude control.
This casually higher percentage of dopaminergic neuronal
loss is probably a consequence of the doubled volume of
microinfusion alongside the still possible different stereotaxic
positioning of the microinfusion needle in the SNpc, due to the
individual differences between rats, despite the fact that we used
the appropriate and identical stereotaxic coordinates and age
of rats in both experimental groups. There is evidence that the
volume of microinfusion is more critical than the concentration
for any pharmacological stimulation or lesion in vivo, or in
other words, for a “selective” recruitment of a certain neuronal
population within the brain (Bjelobaba and Saponjic, 2013).
In contrast to the rat model of hemiparkinsonism, that
we used in this study, our previous studies in the rat model
of PD cholinopathy (a severely impaired PPT cholinergic
thalamo-cortical innervation; bilateral PPT lesion) demonstrated
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FIGURE 5 | Impact of the unilateral SNpc lesion on the sleep spindles (SS) and high voltage sleep spindles (HVS) dynamics during NREM and REM sleep. Individual
examples of SS and HVS during simultaneous NREM and REM sleep in the MCx and hippocampus (Hipp) in the control (A,E), and the SNpc lesioned rats (B,F) with
their characteristic band pass filters used for their detection and extraction from the EEG signal (11–17 Hz band pass filter for SS; 4.1–10 Hz band pass filter for
HVS), the corresponding EMGs and spectrograms, and the impact of the unilateral SNpc lesion on SS (C,D) and HVS (G,H) durations.
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TABLE 3 | High voltage sleep spindles (HVS) dynamic during NREM and REM sleep.
HVS
NREM/REM HVSdur/h
MCx n nHVS Density/h (1/min) dur/h (min) (min) HVSdur (s) HVSf (Hz)
NREM
Control 3/10 (30%) 4 25.63 ± 2.12
12 µg/1 µl SNpc lesion 5/8 (63%) 19 0.08 ± 0.01 26.55 ± 1.89 0.44 1.39 ± 0.07 7.07 ± 0.30
12 µg/2 µl SNpc lesion 3/9 (33%) 11 23.23 ± 5.58
REM
Control 6/10 (60%) 55 1.01 ± 0.16 7.25 ± 0.62 2.68 2.92 ± 0.14 7.92 ± 0.11
12 µg/1 µl SNpc lesion 8/8 (100%) 230 1.63 ± 0.16∗∗ 8.69 ± 0.76 9.85 2.57 ± 0.08∗∗ 7.92 ± 0.05∗∗
12 µg/2 µl SNpc lesion 9/9 (100%) 218 1.43 ± 0.11 8.16 ± 0.85 9.61 2.84 ± 0.08 7.93 ± 0.05
Hipp
NREM
Control 1/10 (10%) 3 25.63 ± 2.12
12 µg/1 µl SNpc lesion 1/8 (13%) 1 26.55 ± 1.89
12 µg/2 µl SNpc lesion 1/9 (11%) 9 23.23 ± 5.58
REM
Control 6/10 (60%) 60 1.22 ± 0.27 7.25 ± 0.62 2.78 2.98 ± 0.01 7.60 ± 0.09∗
12 µg/1 µl SNpc lesion 7/8 (88%) 133 0.87 ± 0.10∗ 8.69 ± 0.76 5.23 2.36 ± 0.08 7.68 ± 0.08∗
12 µg/2 µl SNpc lesion 7/9 (78%) 131 1.09 ± 0.18 8.16 ± 0.85 5.05 2.51 ± 0.08∗ 7.67 ± 0.06∗
n, number of rats; nHVS, total number of extracted HVS used for analysis of HVS dynamic; density/h, mean frequency of HVS per hour of NREM/REM sleep (1/min);
NREM/REM dur/h, mean NREM/REM duration (minutes); HVS dur/h, total duration of HVS extracted during 1 h of NREM/REM sleep (minutes); HVSdur, mean HVS
duration (seconds); HVSf, mean HVS intrinsic frequency (Hz).
Bold numbers indicate the statistically significant mean values vs. their corresponding control values at p ≤ 0.05; ∗ indicates statistically significant inter-structure mean
values at p ≤ 0.05; ∗∗ indicates statistically significant NREM/REM mean values at p ≤ 0.05. All comparisons were made using the Mann–Whitney U test.
There were no mean values in the gray rows, and they were not compared since the HVS were present in less than 50% of the rats.
the topographically distinct EEG microstructures in the
sensorimotor and MCx during NREM and REM sleep, expressed
mainly as an attenuated delta vs. augmented beta amplitudes
during Wake and NREM sleep, and as augmented beta and
gamma amplitudes during REM sleep, with no changes in sleep
architecture (Petrovic et al., 2013a,b). Beside the augmented
cortical activation, the bilateral PPT cholinergic neuronal loss
>20% across the overall PPT rostro-caudal dimension, for each
brain side, sustainably increased the Wake/REM and REM/Wake
transitions followed by increased NREM/REM and REM/NREM
transitions (Petrovic et al., 2013a,b), and induced the emergence
of two REM sleep states, particularly in the MCx (Petrovic
et al., 2013b, 2014). These two REM states were with differential
sensorimotor and motor cortical drives to the dorsal nuchal
muscles, mainly expressed as impaired beta oscillation drive
(Petrovic et al., 2014). In addition, the hallmarks of an earlier
aging onset in the rat model of PD cholinopathy was expressed
as a unique REM sleep phenomenon – REM “enriched” with
SSs of a different pattern, prolonged duration, and slower
intrinsic frequency in the MCx as well as the altered motor
cortical drive (Ciric et al., 2016, 2017). Moreover, one recent
study in the rat model of PD cholinopathy did not show any
change in the sleep architecture, but demonstrated a severe and
long-lasting EEG microstructure disorder during NREM sleep in
the hippocampus, expressed earlier than hypokinesia (Ciric et al.,
2018). This long-lasting hippocampal NREM sleep disorder
was expressed mainly, from the onset, as delta amplitude
augmentation vs. beta amplitude attenuation, and became a
common feature of NREM sleep in the hippocampus and MCx,
at the end of follow-up period, 91 days after the bilateral PPT
lesion (Ciric et al., 2018).
All aforementioned distinct sleep disorders or the differential
impact of the impaired SNpc dopaminergic innervation vs. the
impaired PPT cholinergic thalamo-cortical innervation on the
sleep architectures and sleep state related EEG microstructues
demonstrate the important and distinct regulatory roles of
both neurotransmitter systems in PD neuropathology. The
tonically augmented theta amplitude across all sleep states in
the MCx and during Wake and REM in the hippocampus,
caused by the SNpc dopaminergic neuronal loss, suggests the
importance of dopaminergic innervation for the theta rhythm
generation control.
Moreover, in this study we demonstrate that although SS
are the hallmarks of NREM sleep, they also occur during REM
sleep in the MCx and hippocampus of control rats. In addition,
whereas the SS were always longer during REM sleep than
during NREM sleep in the MCx and hippocampus, they were
consistently slower in the hippocampus (Table 2). The unilateral
SNpc dopaminergic neuronal loss increased the density of the SS
in the MCx and hippocampus and shortened the SS in the MCx
during NREM sleep, but did not change their intrinsic frequency
(Table 2 and Figures 5A–D).
In addition, our present results show that HVS are the
hallmarks of REM sleep in control rats and that they are, as in
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FIGURE 6 | Coherence spectra of all the conventional EEG frequency oscillations between the MCx and hippocampus (Hipp) during Wake, NREM and REM sleep
14 and 42 days following the unilateral SNpc lesions with two distinct microinfusions of 6-OHDA. Arrows indicate the statistically significant mean coherence values
at p ≤ 0.05, obtained using the Mann–Whitney U tests, while their directions indicate the increased or decreased coherences following the unilateral SNpc lesions
vs. controls.
the SS, slower in the hippocamus than in the MCx (Table 3).
The unilateral SNpc dopaminergic neuronal loss increased the
density of HVS in the MCx and consistently shortened HVS in the
hippocampus during REM sleep without any alteration in their
intrinsic frequency (Table 3 and Figures 5E–H).
Our present study demonstrates that both the SS pattern and
duration are state dependent, whereas their intrinsic frequency
is brain structure dependent. Beside the fact that the HVS are
typical of REM sleep and SS are typical of NREM sleep, both
types of SSs were longer when they occurred during REM
sleep, indicating the importance of the REM sleep neurochemical
regulatory substrate for SS generation and duration control, or for
the control of the reticulo-thalamic (RT)–thalamo-cortical (TC)–
cortico-thalamic (CT) neuronal loop. In addition, both types of
SSs were slower within the hippocampus vs. the MCx, during the
state where they typically occurr (NREM or REM), indicating the
important regulatory impact of the local neuronal network on the
intrinsic frequency of both SSs types.
We should note here that as sleep depth progresses, the RT
neurons begin to fire in bursts, generating massive inhibitory
postsynaptic potentials in the TC neurons (Piantoni et al., 2016).
While the RT neurons plays the central role of pacemaker
in the generation of SS oscillation, the reciprocal connections
between excitatory and inhibitory neurons in the thalamus
and between TC and CT neurons are essential in defining the
spatiotemporal dynamics of spindle activity (Piantoni et al.,
2016). On the other hand, the duration of the SSs is determined
by the duration of RT neuronal activity, and RT neurons
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FIGURE 7 | Spontaneous locomotor activity following the unilateral SNpc lesion (A) and during inter-session habituation over three consequtive days at each time
point (B) with respect to the physiological controls (Control-p) and implanted controls (Control-i), expressed as the means for 5 min intervals (left panels) or as the
means ± SE for 30 min intervals (right panels) at 14 and at 42 days following the SNpc lesion. The time-dependent profiles of locomotor activity (left panels) were
similar for all the experimental groups as well as for the entire registration period (right panels). There was no alteration in the basal locomotor activity. Importantly, in
contrast to the physiological controls (Control-p; n = 6) and the implanted controls (Control-i; n = 7), the time-dependent profiles of locomotor activity during
inter-session habituation in the unilaterally SNpc lesioned rats (12 µg/1 µl SNpc lesion, n = 6; and 12 µg/2 µl SNpc lesion, n = 6), and over three consecutive days,
only indicated impaired spatial memory abilities from the onset of SNpc dopaminergic neuronal loss. Stars indicate the statistically significant mean values at
p ≤ 0.05 obtained using the Mann–Whitney U tests.
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firing sharply dropped before the termination of all spindles
(Bartho et al., 2014).
Furthermore, studies in both animal models and humans have
described SSs as being highly synchronized between multiple
cortical regions, but recent human studies have demonstrated
that SSs are isolated events (Piantoni et al., 2016). In addition,
the phase-locked firing of the hippocampal cells associated
with locally recorded SSs in sleeping rat raises the possibility
that similar mechanisms are involved in the generation of
hippocampal theta and SS activity (Buzsaki et al., 1994). There
is also evidence for increased functional connectivity between the
hippocampus and the cortex during SSs (Andrade et al., 2011).
Furthermore, the hippocampal spindles arise from a circuitry
involving the RT and the anterior thalamic nucleus, with which
the hippocampus shares reciprocal connections (Aggleton et al.,
2010), and they are more spatially restricted and with lower
synchrony (Frauscher et al., 2015), suggesting that very local
pathways connect the thalamus to the hippocampus. Moreover,
it has also been shown that hippocampal SSs are a physiological
sleep-related phenomenon and that they precede by several
minutes neocortical sleep onset in humans, with increasing delays
along the cortical rostro-caudal axis (Sarasso et al., 2014). It has
also been demonstrated that during SSs, the cortex is functionally
“deafferented” from its hippocampal inputs, due to the bursting
mode of activity of the thalamic inputs that recruit massive
intracortical inhibitory neurons, which itself produces a local
deafferentation of the cortical area concerned, regardless of the
input source (Peyrache et al., 2011).
Since in our present study the unilateral SNpc lesion increased
the density of the SS during NREM, and likewise of the HVS
during REM sleep, but shortened the SS in the MCx and the
HVS in both the MCx and the hippocampus, it seems that
the dopaminergic neuronal loss potentiates SS generation at the
cortical and hippocampal level, but shortened them throughout
the frequently potentiated inhibition of the RT neurons. On
the other hand, one recent study demonstrated an altered HVS
dynamic (prolonged HVS in the MCx with no change of intrinsic
frequency vs. shortened and slower HVS in the hippocampus)
during REM sleep in the hippocampus and MCx, as the hallmark
of PPT thalamo-cortical cholinergic dysregulation in the rat
model of PD cholinopathy (Ciric et al., 2018). In accordance with
that, our present results show that the impacts of impaired SNpc
dopaminergic and PPT thalamo-cortical cholinergic innervations
are equally expressed in terms of HVS generation at the motor
cortical level (increased density), and in terms of HVS duration
at the hippocampal level (decreased duration) during REM
sleep. Conversely, the impaired PPT thalamo-cortical cholinergic
innervation during REM sleep prolonged the HVS duration in
the MCx with no change in their intrinsic frequency, while
simultaneously decreasing the duration and intrinsic frequency
of hippocampal HVS (Ciric et al., 2018).
Anatomically, the basal ganglia and the PPT share many
similarities: they are both heterogeneous structures with similar
patterns of inputs and outputs, including cortex, thalamus,
amygdala and brainstem, and the PPT has a unique connection
reciprocity with the basal ganglia (Mena-Segovia et al., 2004).
There is evidence for the similar functions of the basal ganglia and
PPT including relevance to locomotion, memory consolidation
and sleep regulation (Mena-Segovia et al., 2004). In addition,
a new circuitry for NREM and REM sleep regulation in the PD
was suggested – a triad composed of PPT, SNpc, and striatum
(Targa et al., 2016). Furthermore, the functional connectivity of
the PPT and deep cerebellar nuclei (Vitale et al., 2016), suggested
the PPT as an interface device between the basal ganglia and
the cerebellum in both motor control and cognitive functions
(Mori et al., 2016). The PPT is a major source of acetylcholine
for the SNpc and an important source of nigrostriatal pathway
excitation (Mena-Segovia et al., 2008; Dautan et al., 2014; Targa
et al., 2016). Although the PPT and laterodorsal tegmental
nucleus (LDT) constitute the only external source of cholinergic
innervation of the striatal complex (Dautan et al., 2016), the
PPT predominantly targets the dorsolateral striatum, whereas
the LDT targets the dorsomedial striatum and the nucleus
accumbens (Dautan et al., 2014). On the other hand, both the
PPT and the hippocampus receive dopaminergic innervation
from the SNpc (Breit et al., 2001; Edelmann and Lessmann, 2018;
French and Muthusamy, 2018).
Our present results reveal that the impaired SNpc
dopaminergic innervation, like the impaired PPT cholinergic
innervation, increased the density of both types of SSs, but
decreased their duration, suggested a disorder in the thalamo-
cortical regulatory network, that was expressed during both
NREM and REM sleep. The altered SS dynamics might be
due to the tonically decreased dopaminergic impact through
the hippocampus, via the PPT, or indirectly through the
basal-ganglia-thalamo-cortical loop.
Moreover, our present study demonstrates that the
impaired SNpc dopaminergic innervation severely altered
the synchronization of the conventional EEG oscillations
between the MCx and the hippocampus during different sleep
states (Figure 6). We should note here that we did not find
different effects on the sleep architecture, sleep state related
EEG microstructures, or on the SS and HVS dynamics, due
to the topographically distinct dopaminergic neuronal loss
following the SNpc lesion using 12 µg/2 µl vs. 12 µg/1 µl
of 6-OHDA (a higher percentage of dopaminergic neuronal
loss, mostly caudally, in the SNpc; see Figure 1). However,
by using the coherence spectra we were able to identify a distinct
synchronization between the hippocampus and MCx during
different sleep states, between the two groups of SNpc lesioned
rats. All the desynchronizations between the MCx and the
hippocampus, in different sleep states, caused by the SNpc
dopaminergic neuronal loss, particularly the theta and sigma
coherences, in the rats lesioned using 12 µg/2 µl vs. 12 µg/1 µl
of 6-OHDA, became synchronized 42 days after the SNpc lesion,
but only during REM sleep (Figure 6 Day 42, bottom panel).
Thus, the increased theta and sigma synchronizations between
the MCx and hippocampus became a common feature in both
groups of SNpc lesioned rats only during REM sleep (Figure 6
Day 42, bottom panel), probably due to the increased density
of the HVS in the MCx and their simultaneous presence in
the hippocampus. These results indicate the most caudal part
of SNpc as an important source of hippocampal innervation
and the REM sleep state as an important regulatory substrate
(during REM there is the highest acetylcholine concentration vs.
the lowest noradrenergic and serotonergic concentration) that
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facilitates synchronization between the MCx and hippocampus
in the hemiparkinsonian rat. It is important to mention here that
thalamo-cortical system controls vigilance states and gates the
perception of sensory stimulation (Steriade, 2006), and that the
HVS presents an expression of the brain state that facilitates the
detection of weak sensory stimulation (Nicolelis and Fanselow,
2002; Wiest and Nicolelis, 2003).
Moreover, in contrast to delayed hypokinesia developed in the
PD cholinopathy (Ciric et al., 2018), in the hemiparkinsonian
rats, we did not find any alterations to spontaneous locomotor
activity (Figure 7A), stereotypic or vertical activity, except
a long-lasted alteration of the habituatal response that only
indicated their impaired spatial memory abilities (Figure 7B,
bottom panels).
We have demonstrated both long-lasting sleep fragmentation
and augmented theta amplitude during the different sleep
states of the MCx and Hipp in hemiparkinsonian rats.
Moreover, the increased density of SS in the MCx and
Hipp during NREM, consistently shorter in the Hipp, and
the increased density of HVS in the MCx along with the
presence of a consistently shorter HVS in the Hipp during
REM sleep, pobably leads to the augmentation of theta
and sigma synchronizations between the MCx and Hipp
during REM sleep. Our results provide novel evidence
for an importance of SNpc dopaminergic innervation in
sleep regulation, theta rhythm generation, and the control
of SSs dynamics, and highlight the important role of the
underlying REM sleep neurochemical regulatory substrate
in HVS generation and duration, and in the cortico-
hippocampal synchronizations of EEG oscillation control in
hemiparkinsonian rats.
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